Index DJIA, S&P 500
P/E 141.95
EPS (ttm) 0.90
Insider Own 0.15%
Shs Outstand 2.53B
Perf Week -2.81%
Market Cap 322.94B
Forward P/E 12.92
EPS next Y 9.87
Insider Trans -10.71%
Shs Float 2.53B
Perf Month -0.12%
Income 2.31B
PEG 2.11
EPS next Q 2.13
Inst Own 78.61%
Short Float 0.81%
Perf Quarter 0.87%
Sales 61.06B
P/S 5.29
EPS this Y 471.17%
Inst Trans 0.64%
Short Ratio 2.49
Perf Half Y 23.98%
Book/sh 14.84
P/B 8.59
EPS next Y 14.43%
ROA 0.34%
Short Interest 20.43M
Perf Year 7.86%
Cash/sh 2.83
P/C 45.10
EPS next 5Y 67.38%
ROE 0.87%
52W Range 99.14 - 133.10
Perf YTD 16.96%
Dividend Est. 3.23 (2.53%)
P/FCF 35.32
EPS past 5Y -42.70%
ROI 3.19%
52W High -4.20%
Beta 0.42
Dividend TTM 3.00 (2.35%)
Quick Ratio 1.00
Sales past 5Y 7.72%
Gross Margin 77.93%
52W Low 28.62%
ATR (14) 2.11
Dividend Ex-Date Mar 14, 2024
Current Ratio 1.25
EPS Y/Y TTM -97.48%
Oper. Margin 9.16%
RSI (14) 50.30
Volatility 1.55% 1.48%
Employees 72000
Debt/Eq 0.97
Sales Y/Y TTM 6.95%
Profit Margin 3.78%
Recom 1.52
Target Price 142.30
Option/Short Yes / Yes
LT Debt/Eq 0.92
EPS Q/Q 69.28%
Payout 2065.60%
Rel Volume 0.76
Prev Close 128.26
Sales Surprise 3.75%
EPS Surprise 9.79%
Sales Q/Q 8.15%
Earnings Apr 25 BMO
Avg Volume 8.21M
Price 127.51
SMA20 0.14%
SMA50 0.85%
SMA200 12.27%
Trades
Volume 6,221,846
Change -0.58%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-11-24 Downgrade
Societe Generale
Hold → Sell
$104
Jan-04-24 Upgrade
TD Cowen
Market Perform → Outperform
$125 → $135
Nov-09-23 Initiated
Deutsche Bank
Buy
$115
Oct-27-23 Upgrade
BMO Capital Markets
Market Perform → Outperform
$132
Oct-20-23 Upgrade
UBS
Neutral → Buy
$117 → $122
Jul-14-23 Initiated
HSBC Securities
Hold
$123
Apr-13-23 Upgrade
Citigroup
Neutral → Buy
$105 → $130
Mar-28-23 Downgrade
Societe Generale
Buy → Hold
Mar-13-23 Downgrade
Wells Fargo
Overweight → Equal Weight
$120 → $115
Mar-06-23 Initiated
Jefferies
Buy
$125
Feb-22-23 Upgrade
Wolfe Research
Peer Perform → Outperform
$127
Jan-04-23 Upgrade
BofA Securities
Neutral → Buy
$110 → $130
Nov-18-22 Initiated
Credit Suisse
Outperform
$120
Oct-10-22 Upgrade
Guggenheim
Neutral → Buy
Sep-14-22 Upgrade
Berenberg
Hold → Buy
$95 → $100
Jul-06-22 Upgrade
Daiwa Securities
Neutral → Buy
$89 → $102
Jun-06-22 Resumed
SVB Leerink
Outperform
$102
Apr-06-22 Resumed
Morgan Stanley
Equal-Weight
$80
Dec-17-21 Initiated
Goldman
Buy
$93
Dec-16-21 Initiated
Daiwa Securities
Neutral
$70
Show Previous Ratings
Today 09:50AM
May-02-24 02:53PM
May-01-24 06:52PM
07:15AM
Apr-30-24 08:44AM
09:00AM
Loading…
Apr-29-24 09:00AM
Apr-28-24 06:54PM
Apr-27-24 09:14AM
Apr-26-24 10:59AM
Apr-25-24 05:54PM
04:09PM
03:30PM
02:29PM
12:52PM
12:09PM
11:42AM
Loading…
11:42AM
(The Wall Street Journal)
11:34AM
11:23AM
10:54AM
10:30AM
09:13AM
(The Wall Street Journal)
09:13AM
(The Wall Street Journal)
07:30AM
07:04AM
06:44AM
(Associated Press Finance)
06:33AM
06:30AM
06:30AM
Apr-24-24 05:50PM
Apr-23-24 07:49AM
02:39PM
Loading…
Apr-22-24 02:39PM
11:10AM
09:15AM
Apr-21-24 10:49AM
Apr-19-24 07:04AM
Apr-18-24 04:27PM
10:01AM
Apr-17-24 05:50PM
08:00AM
Apr-16-24 03:17PM
Apr-15-24 07:48AM
Apr-12-24 06:40AM
Apr-11-24 05:50PM
Apr-08-24 11:38PM
02:00PM
Apr-07-24 02:00PM
Apr-06-24 08:47PM
Apr-05-24 05:45PM
05:33AM
Apr-04-24 07:38AM
06:45AM
05:36AM
Apr-03-24 05:50PM
08:00AM
Apr-01-24 09:50AM
06:45AM
Mar-29-24 10:51AM
Mar-28-24 05:50PM
09:15AM
06:45AM
Mar-27-24 04:36PM
04:00PM
02:58PM
12:20PM
11:54AM
10:58AM
10:26AM
(The Wall Street Journal)
10:10AM
09:53AM
09:00AM
08:50AM
08:39AM
07:36AM
07:36AM
Mar-26-24 06:21PM
05:07PM
(The Wall Street Journal)
01:12PM
09:30AM
05:15AM
Mar-24-24 09:54AM
Mar-22-24 05:45PM
10:26AM
Mar-21-24 03:00PM
(The Wall Street Journal)
10:25AM
06:45AM
Mar-20-24 05:50PM
Mar-19-24 09:00AM
Mar-15-24 04:23PM
12:17PM
06:45AM
Mar-14-24 07:01PM
05:45PM
Mar-13-24 05:50PM
09:03AM
09:00AM
07:01AM
03:00AM
02:45AM
Mar-11-24 04:53PM
08:15AM
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Romanelli Joseph President, Human Health Int?l May 02 '24 Option Exercise 128.80 2,262 291,346 21,831 May 02 04:29 PM Smart Dalton SVP Fin. - Global Controller May 02 '24 Option Exercise 128.80 381 49,073 3,048 May 02 04:23 PM Merck & Co., Inc. 10% Owner Mar 11 '24 Buy 23.00 21,397,205 492,135,715 1,000 Mar 11 03:27 PM Davis Robert M Chairman, CEO & President Feb 14 '24 Option Exercise 73.73 85,021 6,268,598 433,348 Feb 15 04:01 PM Litchfield Caroline EVP & CFO Feb 14 '24 Option Exercise 58.08 38,291 2,223,941 89,199 Feb 15 04:03 PM Davis Robert M Chairman, CEO & President Feb 14 '24 Sale 125.40 85,021 10,661,574 348,327 Feb 15 04:01 PM Litchfield Caroline EVP & CFO Feb 14 '24 Sale 125.50 38,291 4,805,520 50,908 Feb 15 04:03 PM Davis Robert M Chairman, CEO & President Feb 13 '24 Option Exercise 74.18 150,000 11,127,160 498,327 Feb 15 04:01 PM Davis Robert M Chairman, CEO & President Feb 13 '24 Sale 125.85 150,000 18,877,424 348,327 Feb 15 04:01 PM Romanelli Joseph President, Human Health Int?l Feb 13 '24 Sale 124.89 1,000 124,888 19,569 Feb 14 04:03 PM Li Dean Y Executive VP & President, MRL Feb 09 '24 Option Exercise 62.07 14,702 912,553 60,944 Feb 12 04:03 PM Li Dean Y Executive VP & President, MRL Feb 09 '24 Sale 125.50 14,702 1,845,083 46,242 Feb 12 04:03 PM Williams David Michael EVP,Chief Info&Digital Officer Feb 07 '24 Sale 127.57 1,451 185,108 19,812 Feb 08 04:04 PM MIZELL STEVEN EVP, Chief HR Officer Feb 02 '24 Option Exercise 73.65 32,994 2,430,159 74,313 Feb 02 04:07 PM Zachary Jennifer EVP, General Counsel Feb 02 '24 Option Exercise 87.10 19,417 1,691,221 78,557 Feb 02 04:05 PM Oosthuizen Johannes Jacobus President, U.S. Market Feb 02 '24 Option Exercise 78.80 20,937 1,649,906 42,286 Feb 05 04:01 PM MIZELL STEVEN EVP, Chief HR Officer Feb 02 '24 Sale 126.65 50,694 6,420,349 23,619 Feb 02 04:07 PM Zachary Jennifer EVP, General Counsel Feb 02 '24 Sale 126.97 49,499 6,284,779 29,058 Feb 02 04:05 PM Oosthuizen Johannes Jacobus President, U.S. Market Feb 02 '24 Sale 127.17 18,959 2,411,111 23,327 Feb 05 04:01 PM Oosthuizen Johannes Jacobus President, U.S. Market Nov 09 '23 Sale 102.38 2,081 213,061 18,191 Nov 13 07:36 AM DeLuca Richard R. EVP&Pres, Merck Animal Heallth Nov 08 '23 Sale 105.03 43,823 4,602,668 111,764 Nov 09 09:04 AM Oosthuizen Johannes Jacobus President, U.S. Market Oct 30 '23 Option Exercise 102.82 915 94,080 20,723 Oct 31 11:08 AM MIZELL STEVEN EVP, Chief HR Officer Aug 14 '23 Sale 109.01 4,250 463,292 22,935 Aug 15 04:08 PM Guindo Chirfi Chief Marketing Officer Aug 03 '23 Option Exercise 105.70 36,901 3,900,436 38,342 Aug 04 04:17 PM MIZELL STEVEN EVP, Chief HR Officer Aug 03 '23 Sale 105.49 4,500 474,701 27,185 Aug 04 04:06 PM Romanelli Joseph President, Human Health Int?l Aug 02 '23 Sale 107.37 59 6,335 0 Aug 03 04:08 PM Romanelli Joseph President, Human Health Int?l Aug 02 '23 Sale 107.37 30 3,221 20,569 Aug 03 04:08 PM Karachun Rita A Sr. VP Fince-Global Controller May 04 '23 Option Exercise 65.24 16,824 1,097,552 61,585 May 05 04:54 PM Oosthuizen Johannes Jacobus President, U.S. Market May 04 '23 Option Exercise 118.22 907 107,226 20,207 May 05 05:09 PM Klobuchar Michael A EVP - Chief Strategy Officer May 04 '23 Option Exercise 118.22 885 104,625 19,476 May 05 05:06 PM LeCointe-Cephas Lisa SVP Chief Ethics & Com Officer May 04 '23 Option Exercise 118.22 813 96,113 5,421 May 05 05:01 PM Zachary Jennifer EVP, General Counsel May 04 '23 Sale 117.59 19,141 2,250,834 35,128 May 05 05:13 PM Karachun Rita A Sr. VP Fince-Global Controller May 04 '23 Sale 117.53 15,875 1,865,843 45,710 May 05 04:54 PM
Index RUT
P/E -
EPS (ttm) -1.55
Insider Own 31.78%
Shs Outstand 226.26M
Perf Week 8.87%
Market Cap 2.10B
Forward P/E -
EPS next Y -1.86
Insider Trans -1.51%
Shs Float 162.03M
Perf Month 1.26%
Income -328.07M
PEG -
EPS next Q -0.42
Inst Own 71.84%
Short Float 23.89%
Perf Quarter -4.84%
Sales 44.58M
P/S 47.10
EPS this Y -9.14%
Inst Trans 4.55%
Short Ratio 6.05
Perf Half Y 73.67%
Book/sh 1.98
P/B 4.46
EPS next Y -7.82%
ROA -48.42%
Short Interest 38.70M
Perf Year 71.32%
Cash/sh 1.66
P/C 5.32
EPS next 5Y 12.00%
ROE -69.12%
52W Range 4.55 - 16.75
Perf YTD -10.34%
Dividend Est. -
P/FCF -
EPS past 5Y -43.41%
ROI -64.59%
52W High -47.21%
Beta 0.85
Dividend TTM -
Quick Ratio 4.70
Sales past 5Y 132.77%
Gross Margin -37.61%
52W Low 94.29%
ATR (14) 0.59
Dividend Ex-Date -
Current Ratio 4.70
EPS Y/Y TTM -13.81%
Oper. Margin -808.21%
RSI (14) 52.55
Volatility 7.74% 5.83%
Employees -
Debt/Eq 0.11
Sales Y/Y TTM 11.88%
Profit Margin -735.99%
Recom 2.43
Target Price 13.00
Option/Short Yes / Yes
LT Debt/Eq 0.10
EPS Q/Q -28.81%
Payout -
Rel Volume 0.62
Prev Close 8.79
Sales Surprise -46.60%
EPS Surprise 6.40%
Sales Q/Q -20.36%
Earnings May 09 AMC
Avg Volume 6.39M
Price 8.84
SMA20 8.60%
SMA50 -12.23%
SMA200 -4.44%
Trades
Volume 3,935,577
Change 0.57%
Date
Action
Analyst
Rating Change
Price Target Change
May-22-23 Initiated
Morgan Stanley
Equal-Weight
$8
Mar-16-23 Initiated
Needham
Buy
$17
Sep-16-22 Initiated
KeyBanc Capital Markets
Overweight
$20
Apr-18-22 Downgrade
BofA Securities
Buy → Neutral
$10
Mar-04-22 Downgrade
SVB Leerink
Outperform → Mkt Perform
$10
Sep-21-21 Initiated
Berenberg
Buy
$37
May-11-21 Initiated
SVB Leerink
Outperform
$33
May-11-21 Initiated
KeyBanc Capital Markets
Overweight
$36
May-11-21 Initiated
JP Morgan
Neutral
$32
May-11-21 Initiated
Goldman
Neutral
$34
May-11-21 Initiated
BofA Securities
Buy
$31
Show Previous Ratings
Today 05:50PM
May-02-24 09:00AM
08:00AM
May-01-24 08:01AM
Apr-30-24 07:29AM
08:00AM
Loading…
08:00AM
Apr-27-24 08:58AM
07:00AM
Apr-25-24 05:50PM
10:30AM
08:01AM
Apr-17-24 05:50PM
07:00AM
Apr-16-24 08:00AM
Apr-15-24 12:54PM
08:00AM
Loading…
08:00AM
Apr-10-24 05:50AM
Apr-08-24 09:00AM
Apr-04-24 08:45AM
01:31AM
Apr-03-24 09:35AM
Apr-02-24 08:00AM
Apr-01-24 12:00PM
Mar-26-24 08:00AM
Mar-22-24 01:29AM
Mar-18-24 01:00PM
Mar-15-24 04:54PM
01:49AM
Mar-11-24 04:00AM
Mar-07-24 10:28AM
02:58PM
Loading…
Mar-01-24 02:58PM
02:00PM
07:59AM
Feb-28-24 06:44PM
10:56AM
Feb-27-24 06:35PM
05:42PM
(Associated Press Finance)
04:34PM
04:05PM
Feb-24-24 03:08AM
Feb-22-24 09:37AM
Feb-21-24 11:27PM
Feb-20-24 07:59AM
Feb-19-24 05:13PM
10:00AM
09:00AM
Feb-18-24 09:00AM
Feb-16-24 10:50AM
02:53AM
Feb-15-24 06:27PM
04:17PM
(Investor's Business Daily)
03:46PM
03:17PM
Feb-10-24 02:58AM
Feb-09-24 02:23AM
Feb-08-24 10:30AM
Feb-07-24 10:00AM
Jan-29-24 05:49PM
Jan-28-24 08:45AM
Jan-27-24 01:04PM
Jan-25-24 11:52PM
11:55AM
Jan-24-24 09:00AM
Jan-18-24 09:01PM
Jan-15-24 08:45AM
Jan-13-24 05:20AM
Jan-12-24 06:11AM
Jan-11-24 01:11PM
Jan-09-24 02:16PM
Jan-08-24 10:59AM
08:23AM
Jan-04-24 07:59AM
Jan-03-24 11:15AM
08:00AM
Jan-02-24 01:57PM
Dec-29-23 07:02PM
Dec-22-23 06:22AM
Dec-20-23 07:59AM
Dec-19-23 12:44PM
Dec-17-23 11:30AM
Dec-16-23 01:00PM
Dec-15-23 03:06AM
Dec-14-23 02:31PM
Dec-09-23 11:06AM
Nov-28-23 10:36AM
Nov-26-23 09:30AM
Nov-22-23 11:45AM
09:45AM
Nov-21-23 08:00AM
Nov-18-23 01:13AM
Nov-17-23 01:06AM
Nov-15-23 08:41AM
Nov-09-23 07:11PM
09:41AM
08:02AM
(Associated Press Finance)
08:01AM
07:58AM
Nov-08-23 02:35PM
Nov-02-23 08:05AM
Nov-01-23 06:57AM
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. Its Recursion operating system enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, novel chemistry, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics that radically improve people's lives. The company was founded by Blake Borgeson, Christopher C. Gibson, and Dean Y. Li on November 5, 2013 and is headquartered in Salt Lake City, UT.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Gibson Christopher Chief Executive Officer May 02 '24 Sale 8.47 50,000 423,500 834,820 May 03 06:24 PM Gibson Christopher Chief Executive Officer May 01 '24 Sale 7.73 50,000 386,500 863,524 May 03 06:24 PM Borgeson Blake Director Apr 30 '24 Sale 7.95 11,447 90,964 7,218,414 May 02 05:41 PM Marriott Tina President and COO Apr 25 '24 Option Exercise 1.06 3,000 3,180 546,231 Apr 29 06:41 PM Marriott Tina President and COO Apr 25 '24 Sale 7.67 3,000 23,020 543,231 Apr 29 06:41 PM Secora Michael Chief Financial Officer Apr 17 '24 Option Exercise 2.22 37,500 83,250 1,254,179 Apr 18 05:12 PM Secora Michael Chief Financial Officer Apr 17 '24 Sale 7.58 23,124 175,349 1,231,055 Apr 18 05:12 PM Secora Michael Chief Financial Officer Apr 16 '24 Option Exercise 2.22 37,500 83,250 1,241,679 Apr 18 05:12 PM Secora Michael Chief Financial Officer Apr 16 '24 Sale 7.67 25,000 191,658 1,216,679 Apr 18 05:12 PM Borgeson Blake Director Apr 16 '24 Sale 7.66 11,447 87,725 7,229,861 Apr 18 05:12 PM Gibson Christopher Chief Executive Officer Apr 04 '24 Sale 9.02 40,000 360,800 938,524 Apr 05 05:44 PM Gibson Christopher Chief Executive Officer Apr 04 '24 Sale 9.02 25,000 225,500 0 Apr 05 05:44 PM Gibson Christopher Chief Executive Officer Apr 03 '24 Sale 8.84 40,000 353,600 978,524 Apr 05 05:44 PM Gibson Christopher Chief Executive Officer Apr 03 '24 Sale 8.84 25,000 221,000 0 Apr 05 05:44 PM Borgeson Blake Director Apr 02 '24 Sale 8.82 11,447 100,942 7,241,308 Apr 03 05:42 PM Gibson Christopher Chief Executive Officer Mar 28 '24 Sale 10.10 40,000 404,000 1,043,524 Apr 01 06:40 PM Gibson Christopher Chief Executive Officer Mar 28 '24 Sale 10.10 25,000 252,500 0 Apr 01 06:40 PM Marriott Tina President and COO Mar 21 '24 Option Exercise 1.06 8,000 8,480 647,982 Mar 25 06:39 PM Marriott Tina President and COO Mar 21 '24 Sale 10.75 8,000 85,980 639,982 Mar 25 06:39 PM Borgeson Blake Director Mar 19 '24 Sale 10.79 20,054 216,423 7,252,755 Mar 21 05:38 PM Secora Michael Chief Financial Officer Mar 13 '24 Option Exercise 2.22 37,500 83,250 1,229,179 Mar 14 07:28 PM Secora Michael Chief Financial Officer Mar 13 '24 Sale 11.03 25,000 275,815 1,204,179 Mar 14 07:28 PM Secora Michael Chief Financial Officer Mar 12 '24 Option Exercise 2.22 37,500 83,250 1,216,679 Mar 14 07:28 PM Secora Michael Chief Financial Officer Mar 12 '24 Sale 10.46 25,000 261,375 1,191,679 Mar 14 07:28 PM Gibson Christopher Chief Executive Officer Mar 06 '24 Option Exercise 4.42 39,924 176,384 1,144,843 Mar 08 07:08 PM Gibson Christopher Chief Executive Officer Mar 06 '24 Sale 11.86 36,319 430,682 1,108,524 Mar 08 07:08 PM Gibson Christopher Chief Executive Officer Mar 06 '24 Sale 11.55 25,000 288,823 0 Mar 08 07:08 PM Borgeson Blake Director Mar 05 '24 Sale 12.06 20,054 241,805 7,272,809 Mar 07 06:53 PM Marriott Tina President and COO Feb 22 '24 Option Exercise 1.06 8,000 8,480 647,982 Feb 23 07:22 PM Marriott Tina President and COO Feb 22 '24 Sale 14.89 8,000 119,160 639,982 Feb 23 07:22 PM Borgeson Blake Director Feb 20 '24 Sale 12.32 20,054 247,125 7,292,863 Feb 21 05:37 PM Secora Michael Chief Financial Officer Feb 14 '24 Option Exercise 2.22 37,500 83,250 1,211,351 Feb 15 06:00 PM Secora Michael Chief Financial Officer Feb 14 '24 Sale 10.46 25,000 261,425 1,186,351 Feb 15 06:00 PM Secora Michael Chief Financial Officer Feb 13 '24 Option Exercise 2.22 37,500 83,250 1,198,851 Feb 15 06:00 PM Secora Michael Chief Financial Officer Feb 13 '24 Sale 9.86 25,000 246,560 1,173,851 Feb 15 06:00 PM Gibson Christopher Chief Executive Officer Feb 07 '24 Option Exercise 2.48 31,250 77,500 822,975 Feb 09 05:34 PM Gibson Christopher Chief Executive Officer Feb 07 '24 Sale 9.22 48,272 444,981 774,703 Feb 09 05:34 PM Borgeson Blake Director Feb 06 '24 Sale 9.30 11,447 106,489 7,312,917 Feb 08 06:54 PM Larson Tina Marriott President and COO Jan 25 '24 Option Exercise 1.06 8,000 8,480 422,584 Jan 29 06:52 PM Larson Tina Marriott President and COO Jan 25 '24 Sale 10.35 8,000 82,762 414,548 Jan 29 06:52 PM Borgeson Blake Director Jan 23 '24 Sale 10.58 20,054 212,083 7,324,364 Jan 25 06:13 PM Secora Michael Chief Financial Officer Jan 17 '24 Option Exercise 2.22 37,500 83,250 1,006,014 Jan 18 06:37 PM Secora Michael Chief Financial Officer Jan 17 '24 Sale 10.25 25,000 256,348 981,014 Jan 18 06:37 PM Secora Michael Chief Financial Officer Jan 16 '24 Option Exercise 2.22 37,500 83,250 993,514 Jan 18 06:37 PM Virani Shafique Chief Business Officer Jan 16 '24 Option Exercise 2.22 18,000 39,960 154,748 Jan 18 06:39 PM Secora Michael Chief Financial Officer Jan 16 '24 Sale 10.45 25,000 261,160 968,514 Jan 18 06:37 PM Virani Shafique Chief Business Officer Jan 16 '24 Sale 10.93 18,000 196,740 136,748 Jan 18 06:39 PM Li Dean Y Director Jan 09 '24 Sale 13.66 29,000 396,214 421,000 Jan 11 06:51 PM Borgeson Blake Director Jan 09 '24 Sale 13.62 20,054 273,202 7,344,418 Jan 11 06:50 PM Gibson Christopher Chief Executive Officer Jan 03 '24 Option Exercise 2.48 31,250 77,500 822,578 Jan 05 08:03 PM Gibson Christopher Chief Executive Officer Jan 03 '24 Sale 9.49 30,853 292,804 791,725 Jan 05 08:03 PM Gibson Christopher Chief Executive Officer Jan 03 '24 Sale 9.51 25,000 237,763 0 Jan 05 08:03 PM Larson Tina Marriott President and COO Dec 28 '23 Option Exercise 1.06 8,000 8,480 422,548 Jan 02 04:58 PM Larson Tina Marriott President and COO Dec 28 '23 Sale 10.58 8,000 84,654 414,548 Jan 02 04:58 PM Borgeson Blake Director Dec 26 '23 Sale 10.63 20,054 213,144 7,364,472 Dec 28 05:48 PM Virani Shafique Chief Business Officer Dec 15 '23 Option Exercise 2.22 18,000 39,960 154,748 Dec 19 07:22 PM Virani Shafique Chief Business Officer Dec 15 '23 Sale 9.60 18,000 172,800 136,748 Dec 19 07:22 PM Dar Zavain Director Dec 14 '23 Sale 9.00 20,141 181,269 53,823 Dec 18 06:44 PM Secora Michael Chief Financial Officer Dec 13 '23 Option Exercise 2.22 37,500 83,250 981,014 Dec 14 06:53 PM Secora Michael Chief Financial Officer Dec 13 '23 Sale 7.59 25,000 189,770 956,014 Dec 14 06:53 PM Secora Michael Chief Financial Officer Dec 12 '23 Option Exercise 2.22 37,500 83,250 968,514 Dec 14 06:53 PM Secora Michael Chief Financial Officer Dec 12 '23 Sale 7.39 25,000 184,868 943,514 Dec 14 06:53 PM Borgeson Blake Director Dec 12 '23 Sale 7.40 11,447 84,693 7,384,526 Dec 14 06:51 PM Gibson Christopher Chief Executive Officer Dec 06 '23 Option Exercise 2.48 31,250 77,500 851,157 Dec 08 05:22 PM Gibson Christopher Chief Executive Officer Dec 06 '23 Sale 7.49 59,829 448,394 791,328 Dec 08 05:22 PM Borgeson Blake Director Nov 28 '23 Sale 6.72 11,447 76,918 7,395,973 Nov 30 05:41 PM Larson Tina Marriott President and COO Nov 16 '23 Option Exercise 1.06 3,000 3,180 416,404 Nov 17 05:53 PM Larson Tina Marriott President and COO Nov 16 '23 Sale 6.76 3,000 20,280 413,404 Nov 17 05:53 PM Secora Michael Chief Financial Officer Nov 15 '23 Option Exercise 2.22 37,500 83,250 963,186 Nov 16 06:54 PM Virani Shafique Chief Business Officer Nov 15 '23 Option Exercise 2.22 18,000 39,960 158,351 Nov 17 05:52 PM Secora Michael Chief Financial Officer Nov 15 '23 Sale 7.32 25,000 182,986 938,186 Nov 16 06:54 PM Virani Shafique Chief Business Officer Nov 15 '23 Sale 6.51 18,000 117,180 140,351 Nov 17 05:52 PM Secora Michael Chief Financial Officer Nov 14 '23 Option Exercise 2.22 37,500 83,250 950,686 Nov 16 06:54 PM Secora Michael Chief Financial Officer Nov 14 '23 Sale 6.32 25,000 157,942 925,686 Nov 16 06:54 PM Borgeson Blake Director Nov 14 '23 Sale 6.32 8,885 56,151 7,407,420 Nov 16 06:55 PM Gibson Christopher Chief Executive Officer Nov 01 '23 Option Exercise 2.48 31,250 77,500 873,997 Nov 03 06:14 PM Gibson Christopher Chief Executive Officer Nov 01 '23 Sale 5.20 37,177 193,306 836,820 Nov 03 06:14 PM Gibson Christopher Chief Executive Officer Nov 01 '23 Sale 5.12 25,000 127,995 0 Nov 03 06:14 PM Borgeson Blake Director Oct 31 '23 Sale 5.27 8,885 46,864 7,416,305 Nov 02 07:02 PM Larson Tina Marriott President and COO Oct 26 '23 Option Exercise 1.06 3,000 3,180 421,782 Oct 30 06:26 PM Larson Tina Marriott President and COO Oct 26 '23 Sale 5.63 3,000 16,885 418,782 Oct 30 06:26 PM Borgeson Blake Director Oct 17 '23 Sale 6.58 8,885 58,483 7,425,190 Oct 19 05:34 PM Virani Shafique Chief Business Officer Oct 16 '23 Option Exercise 2.22 18,000 39,960 158,351 Oct 18 05:34 PM Virani Shafique Chief Business Officer Oct 16 '23 Sale 6.30 18,000 113,400 140,351 Oct 18 05:34 PM Secora Michael Chief Financial Officer Oct 11 '23 Option Exercise 2.22 37,500 83,250 938,186 Oct 12 06:07 PM Secora Michael Chief Financial Officer Oct 11 '23 Sale 6.85 25,000 171,312 913,186 Oct 12 06:07 PM Secora Michael Chief Financial Officer Oct 10 '23 Option Exercise 2.22 37,500 83,250 925,686 Oct 12 06:07 PM Secora Michael Chief Financial Officer Oct 10 '23 Sale 7.07 25,000 176,762 900,686 Oct 12 06:07 PM Gibson Christopher Chief Executive Officer Oct 04 '23 Option Exercise 2.48 31,250 77,500 902,541 Oct 06 06:12 PM Gibson Christopher Chief Executive Officer Oct 04 '23 Sale 7.21 59,794 431,025 842,747 Oct 06 06:12 PM Borgeson Blake Director Oct 03 '23 Sale 7.29 8,885 64,778 7,434,075 Oct 05 06:25 PM Larson Tina Marriott President and COO Sep 28 '23 Option Exercise 1.06 3,000 3,180 421,782 Oct 02 06:19 PM Larson Tina Marriott President and COO Sep 28 '23 Sale 7.72 3,000 23,159 418,782 Oct 02 06:19 PM Borgeson Blake Director Sep 19 '23 Sale 8.36 8,885 74,278 7,442,960 Sep 21 06:35 PM Virani Shafique Chief Business Officer Sep 15 '23 Option Exercise 2.22 18,000 39,960 158,351 Sep 19 05:50 PM Virani Shafique Chief Business Officer Sep 15 '23 Sale 8.66 18,000 155,880 140,351 Sep 19 05:50 PM Secora Michael Chief Financial Officer Sep 13 '23 Option Exercise 2.22 37,500 83,250 913,186 Sep 14 06:26 PM Secora Michael Chief Financial Officer Sep 13 '23 Sale 8.69 25,000 217,318 888,186 Sep 14 06:26 PM Secora Michael Chief Financial Officer Sep 12 '23 Option Exercise 2.22 37,500 83,250 900,686 Sep 14 06:26 PM Secora Michael Chief Financial Officer Sep 12 '23 Sale 8.43 25,000 210,632 875,686 Sep 14 06:26 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite